Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (205)

« Back to Publications

Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.

Abuga KM. et al, (2027), The Lancet. Global health

Preclinical characterization of immune responses induced by a candidate gonococcal native outer membrane vesicle vaccine

Onofrio I. et al, (2026), mSphere

Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB.

Freixeiro P. et al, (2026), NPJ vaccines

Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya

Muthumbi EM. et al, (2026), The Journal of Infectious Diseases, 233, e1115 - e1123

Consultation report - gonococcal immunoassays and standards for vaccine development.

MacLennan CA. et al, (2026), Vaccine, 86

Navigating through uncertainty-Experience from the UK national VEXAS MDT.

Pietsch D. et al, (2026), British journal of haematology, 208, 1306 - 1313

The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges ahead

Revie NM. et al, (2026), Vaccine, 76, 128339 - 128339

Vaccines and antimicrobial resistance: from science to policy—introduction

MacLennan CA. and Davies S., (2026), Philosophical Transactions B, 381

Lessons from COVID-19: the 100 Days Mission and antimicrobial resistance

Hatchett R. and MacLennan CA., (2026), Philosophical Transactions B, 381

Vaccines and antimicrobial resistance: from science to policy—summary and outcomes

MacLennan CA. et al, (2026), Philosophical Transactions B, 381

The immunology of infection

Gilchrist JJ. et al, (2026), Medicine United Kingdom, 54, 1 - 8

Estimating the economic burden of invasive non-typhoidal Salmonella infections in low- and middle-income countries

Lee J-S. et al, (2025), BMJ Global Health, 10, e019370 - e019370

Cross-comparison study of three ELISA methodologies to measure Shigella Sonnei O-antigen serum IgG

Stickings P. et al, (2025), mSphere, 10

Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations

Excler J-L. et al, (2025), Vaccine, 62, 127515 - 127515

Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study

Al-Hakim A. et al, (2025), The Lancet Rheumatology, 7, e472 - e484

Load More

1
2
3
4
5
6
7
...
»